Treatment of carbohydrate metabolism disorders
US4237165A · kind A · utility
7Cited by
1References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 4, 1976 |
| Grant date | Dec 2, 1980 |
| Priority date | — |
| Expiry date | Jun 4, 1996 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/135
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions containing a compound selected from 1-(3-trifluoromethyl phenyl)-2-(.beta.-hydroxyethyl)aminopropane and 1-(3-trifluoromethyl phenyl)-2-(.beta.-benzoyloxy ethyl)-aminopropane and physiologically acceptable acid addition salts thereof, useful in the treatment of metabolism disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.